Is telehealth allowed to prescribe Topamax in California?

Introduction

Living with Binge Eating Disorder (BED) can be challenging, but access to treatment has become increasingly convenient thanks to telehealth options. If you’re considering medication management for BED through virtual care, you likely have questions about legality, access, and what to expect. This comprehensive guide breaks down the current telehealth landscape for BED treatment in 2026, focusing specifically on non-controlled medications like Topamax (topiramate) and Wellbutrin (bupropion) that are commonly prescribed off-label for this condition.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Can I Get Binge Eating Disorder Medications via Telehealth?

Yes. For non-controlled medications like Topamax (topiramate) and Wellbutrin (bupropion), telehealth providers can legally prescribe them in every state, provided they’re licensed where you live and follow standard care practices.

These medications are not classified as controlled substances, which means they’re exempt from the stricter federal rules (Ryan Haight Act) that apply to medications like stimulants. While there’s been much attention on DEA policies for controlled substances, for BED treatments using non-controlled medications, telehealth access remains fully open nationwide in 2026.

At Klarity Health, our providers can evaluate you for BED via video appointments and, if appropriate, prescribe these medications without requiring an in-person visit first. Our platform connects you with licensed providers who understand both the medical and psychological aspects of eating disorders.

Do I Need an In-Person Exam Before Starting Treatment?

In most states, you do not need an in-person exam to start BED medications via telehealth. The majority of states have permanently adapted COVID-era flexibilities, allowing a telehealth examination to fulfill the ‘prior examination’ requirement before prescribing.

For example:

• California permits examinations via video or even asynchronous questionnaires if they meet the standard of care
• New York has no in-person requirement for non-controlled prescriptions
• Texas allows remote prescribing for non-controlled medications without requiring face-to-face visits

A few states have some periodic requirements:

• Alabama and Georgia require that a patient be seen in-person within a year if treatment continues long-term, but this can often be done by any collaborating provider
• New Hampshire codified a similar annual check-in requirement

Even in these states, you can always begin treatment online, and your provider will explain any future in-person requirements based on your location.

Who Can Prescribe BED Medications via Telehealth?

In all states, MDs and DOs (physicians) can prescribe Topamax or Wellbutrin for BED via telehealth. Additionally, Nurse Practitioners (NPs) and Physician Assistants (PAs) can also prescribe these medications, though their level of autonomy varies by state:

• In approximately 34 states (plus DC), NPs now have Full Practice Authority, meaning they can evaluate and prescribe independently. Recent additions to this list include Wisconsin, Michigan, Louisiana, and Kansas, which updated their laws between 2023-2025.

• In other states, NPs/PAs must work under a collaborative agreement with a physician. This is common in southeastern states like Florida and Texas. While this doesn’t usually affect your care experience, you might see both the NP’s and supervising physician’s names on your prescription.

• For non-controlled medications like those used for BED, practically any licensed prescriber (MD/DO/NP/PA) at a telehealth service can prescribe these treatments, provided they follow their state’s collaboration rules.

Klarity Health works with licensed providers across various disciplines who are familiar with the specific regulations in your state, ensuring that you receive appropriate care that complies with all legal requirements.

What to Expect During a Telehealth Evaluation for BED

To receive medication for BED via telehealth, you’ll need to meet the clinical criteria for the disorder. During your initial evaluation, expect:

1. Detailed assessment: Providers will ask about your eating behaviors, including episodes of eating an unusually large amount of food within a short period (typically 2 hours), feeling out of control during these episodes, and experiencing these episodes at least once weekly for three months (core DSM-5 criteria).

2. Differential diagnosis: Your provider will ensure your symptoms aren’t better explained by another condition and will check that binge eating isn’t accompanied by compensatory behaviors like purging.

3. Medical history review: Be prepared to discuss your mental health history, previous treatments, medication experiences, and any medical conditions that could impact treatment decisions.

4. Documentation: The provider will document that you meet DSM-5 criteria for BED, obtain your informed consent for telehealth treatment, and record that an appropriate evaluation was conducted.

5. Treatment planning: If medication is appropriate, your provider will explain how the medication works, potential side effects, and what to expect during treatment.

Klarity Health’s platform ensures a thorough evaluation that meets or exceeds the standard of care, while keeping the process convenient and accessible from the comfort of your home.

Who Is Not a Good Candidate for Telehealth BED Treatment?

Safety remains paramount in telehealth care. Certain conditions may require in-person assessment or make some medications unsuitable:

• History of anorexia or bulimia: Bupropion (Wellbutrin) is contraindicated for patients with a history of bulimia or anorexia nervosa due to increased seizure risk. Your provider may recommend alternative treatments.

• Seizure disorders: If you have uncontrolled epilepsy or a seizure disorder, bupropion would be contraindicated, and topiramate would be used with caution.

• Pregnancy or planning pregnancy: Topiramate can cause birth defects (including cleft palate) when taken during pregnancy. Most telehealth providers won’t initiate topiramate for pregnant patients and will advise effective contraception for women of childbearing potential.

• Severe medical instability: If your BED has led to serious health complications like severe obesity with urgent health issues, uncontrolled diabetes, or very high blood pressure, your provider may require an in-person evaluation.

• Need for controlled medications: If your provider determines you need Vyvanse (lisdexamfetamine) – the only FDA-approved medication for BED, which is a controlled substance – telehealth rules are more restrictive, and you might be referred for in-person care.

Understanding Off-Label Medication Use for BED

Neither Topamax nor Wellbutrin is FDA-approved specifically for BED. Topamax is approved for seizures and migraines, while Wellbutrin is approved for depression and smoking cessation. However, off-label prescribing is legal and common in treating many conditions, including BED.

Clinical research supports these choices – studies show bupropion can help reduce binge frequency in some patients, and topiramate at low doses can aid in impulse control and weight management. Your telehealth provider should:

• Explain that the medication is being used off-label
• Discuss the evidence supporting this use
• Review potential risks and benefits
• Document your informed consent

At Klarity Health, our providers thoroughly explain treatment options, including the rationale behind off-label prescribing, ensuring you’re fully informed about your care.

Refills and Follow-Up Care

Since these BED medications are non-controlled, providers can often give refills (up to 6 or 11 months, depending on state limits), meaning you might not need a new prescription every month. However, regular follow-up appointments are important, especially when starting treatment.

A typical telehealth plan might include:

• Initial evaluation
• 2-week or 1-month check-in to monitor medication tolerance
• Monthly or bimonthly follow-ups thereafter

Some states (like New Hampshire, Alabama, Georgia) require a follow-up within 6–12 months for continued telemedicine treatment. Even where not mandated, good practice includes scheduled visits to assess progress, adjust dosage if needed, and ensure safety.

Klarity Health provides structured follow-up care with the same attention to detail you’d expect from in-person treatment, along with convenient messaging capabilities to address concerns between appointments.

Safety and Quality in Telehealth BED Treatment

With the expansion of telehealth, there’s been increased scrutiny of online providers – which ultimately benefits patients by ensuring higher standards. Reputable telehealth platforms implement strict protocols to maintain quality care:

1. Identity verification: Your provider will verify your identity and location at the start of your visit, ensuring they’re licensed in your state and preventing fraud.

2. Thorough evaluation: Expect a detailed assessment lasting 30 minutes or more for an initial BED consultation. If a service only asks a few quick questions before issuing a

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12